Cargando…
Seizure During Infliximab Infusion in a Child With Crohn’s Disease: An Illustration of a Neurologic Adverse Event Associated With Drug Antibodies
Antitumor necrosis factor (anti-TNF) therapy has proven efficacy in the induction and maintenance of remission in children with Crohn’s disease (CD). With the increased use of these medications, several adverse events have been associated, including the emergence of neurologic side effects. While de...
Autores principales: | Joseph, Shelly, Reed, Anna W, Cuffari, Carmen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191561/ https://www.ncbi.nlm.nih.gov/pubmed/37205948 http://dx.doi.org/10.1097/PG9.0000000000000101 |
Ejemplares similares
-
Infliximab therapy in pediatric Crohn’s disease: a review
por: Parashette, Kalyan Ray, et al.
Publicado: (2010) -
The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease
por: Vande Casteele, Niels, et al.
Publicado: (2015) -
Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn's Disease
por: Gomes, Luis Eduardo Miani, et al.
Publicado: (2019) -
The Utility of Contrast Enhanced Ultrasound and Elastography in the Early Detection of Fibro-Stenotic Ileal Strictures in Children with Crohn’s Disease
por: Sidhu, Sarah D., et al.
Publicado: (2023) -
Infliximab‐induced seizures in a patient with Crohn’s disease: a case report
por: Lv, Zhijie, et al.
Publicado: (2021)